Current Editions
Science Spotlight: HTT variant increases risk for fibromyalgia
BioCentury’s roundup of translational innovations also includes engineering bacteria for cancer
Discovery & Translation
Data Byte
FDA’s August PDUFAs revisit rejections
At least two of 11 decisions involve CBER-regulated products that have encountered setbacks. Capricor suffered another Wednesday
Finance
Caldera draws $278M in PIPE, finds quick path from NewCo to NASDAQ
The deal will fund mid-stage development of a bispecific that could improve on ‘efficacy ceiling’ of existing therapies for inflammatory bowel disease
BioCentury ISSN 1097-7201